You are here

  • Home
  • Archive
  • Volume 60, Issue 7
  • Long-term multisystemic efficacy of migalastat on Fabry-associated clinical events, including renal, cardiac and cerebrovascular outcomes

Article metrics

Article menu
Therapeutics
Original research
Long-term multisystemic efficacy of migalastat on Fabry-associated clinical events, including renal, cardiac and cerebrovascular outcomes

 

Online download statistics by month:

Online download statistics by month: December 2022 to November 2024

AbstractFullPdf
Dec 2022353342134
Jan 2023747738246
Feb 2023504505136
Mar 2023405405123
Apr 2023384382115
May 2023337333132
Jun 2023430408108
Jul 2023359353112
Aug 202317417944
Sep 202320119383
Oct 202311911368
Nov 202316516762
Dec 202311310552
Jan 202412210370
Feb 202413510168
Mar 2024165163111
Apr 202414714494
May 202414915299
Jun 202414113968
Jul 202414113664
Aug 202412311876
Sep 202411210232
Oct 202417916756
Nov 202420419481
Total590957422234